Abstract
Introduction: Respiratory disorders remain an important newborn complication. Currently, there have been alarming information about the impact of repeated courses (even one “resque” course) of RDS prophylaxis on the quality of health in childhood and adulthood. Therefore, the search for available tests to determine the fetal lungs maturity in women at high risk of PTB is an important practical problem. Lamellar bodies (LBCs) produced by type II pneumocytes and appearing in the amniotic fluid in 28–32 weeks may serve as a possible such potential marker.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Obstetrics & Gynecology and Reproductive Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
